Skip to main content

Yesterday, Sept. 9, 2015, 76 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $66.60 to $17,709,040.70.

Highlighted Stocks Traded by Insiders:

Cyberonics (CYBX) - FREE Research Report

Laptewicz Joseph E, who is Director at Cyberonics, sold 3,687 shares at $66.95 on Sept. 9, 2015. Following this transaction, the Director owned 17,196 shares meaning that the stake was reduced by 17.66% with the 3,687-share transaction.

The shares most recently traded at $65.13, down $1.82, or 2.79% since the insider transaction. Historical insider transactions for Cyberonics go as follows:

  • 4-Week # shares sold: 12,050
  • 12-Week # shares sold: 22,786
  • 24-Week # shares sold: 47,064

The average volume for Cyberonics has been 304,000 shares per day over the past 30 days. Cyberonics has a market cap of $1.8 billion and is part of the health care sector and health services industry. Shares are up 15.93% year-to-date as of the close of trading on Wednesday.

Cyberonics, Inc., together with its subsidiaries, designs, develops, markets, and sells medical devices to hospitals and ambulatory surgery centers. The company has a P/E ratio of 31.7. Currently, there are 3 analysts who rate Cyberonics a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CYBX - FREE

TheStreet Quant Ratings

rates Cyberonics as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Cyberonics Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Memorial Resource Development (MRD) - FREE Research Report

Habachy Steve Saad, who is Shareholder at Memorial Resource Development, sold 173,451 shares at $20.03 on Sept. 9, 2015. Following this transaction, the Shareholder owned 632,735 shares meaning that the stake was reduced by 21.52% with the 173,451-share transaction.

The shares most recently traded at $19.51, down $0.52, or 2.67% since the insider transaction. Historical insider transactions for Memorial Resource Development go as follows:

  • 4-Week # shares sold: 236,469
  • 12-Week # shares sold: 806,469
  • 24-Week # shares bought: 8,127
  • 24-Week # shares sold: 2.5 million

The average volume for Memorial Resource Development has been 1.8 million shares per day over the past 30 days. Memorial Resource Development has a market cap of $3.8 billion and is part of the basic materials sector and energy industry. Shares are up 8.21% year-to-date as of the close of trading on Wednesday.

Memorial Resource Development Corp., an independent natural gas and oil company, focuses on the acquisition, exploitation, and development of natural gas, natural gas liquids, and oil properties primarily in North Louisiana. The company has a P/E ratio of 19.2. Currently, there are 9 analysts who rate Memorial Resource Development a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MRD - FREE

TheStreet Quant Ratings

rates Memorial Resource Development as a

sell

. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk and generally disappointing historical performance in the stock itself. Get the full

Memorial Resource Development Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Facebook (FB) - FREE Research Report

Stretch Colin, who is VP, Gen. Counsel & Secretary at Facebook, sold 1,000 shares at $89.70 on Sept. 9, 2015. Following this transaction, the VP, Gen. Counsel & Secretary owned 81,100 shares meaning that the stake was reduced by 1.22% with the 1,000-share transaction.

The shares most recently traded at $89.79, up $0.09, or 0.1% since the insider transaction. Historical insider transactions for Facebook go as follows:

  • 4-Week # shares sold: 43,899
  • 12-Week # shares sold: 184,262
  • 24-Week # shares sold: 315,784

The average volume for Facebook has been 33.2 million shares per day over the past 30 days. Facebook has a market cap of $202.3 billion and is part of the technology sector and internet industry. Shares are up 15.92% year-to-date as of the close of trading on Wednesday.

Facebook, Inc. operates as a social networking company worldwide. It provides a set of development tools and application programming interfaces that enable developers to integrate with Facebook to create mobile and Web applications. The company has a P/E ratio of 91.4. Currently, there are 27 analysts who rate Facebook a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FB - FREE

TheStreet Quant Ratings

rates Facebook as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Facebook Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.